1α,25-(OH)2D3 Use on Psoriasis and Ichthyosis
: The present work compared the clinical efficacy of topically applied 1α,25-dihydroxyvitamin D3 (1α,25-(OH)2D3) in 16 cases with psoriasis vulgaris, 5 with ichthyosis vulgaris and 8 with X-linked ichthyosis. Sixty-nine percent of the psoriatic cases responded to 1α,25-(OH)2D3 therapy, whereas no ic...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Okano, Masaki - M.D. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|
| Erschienen: |
Oxford, UK: Blackwell Publishing Ltd ; 1991 |
|---|
| Umfang: |
Online-Ressource |
|---|
| Reproduktion: |
2007 ; Blackwell Publishing Journal Backfiles 1879-2005 |
|---|---|
| Übergeordnetes Werk: |
In: International journal of dermatology - Oxford [u.a.] : Wiley-Blackwell, 1970, 30(1991), 1, Seite 0 |
| Übergeordnetes Werk: |
volume:30 ; year:1991 ; number:1 ; pages:0 |
| Links: |
|---|
| DOI / URN: |
10.1111/j.1365-4362.1991.tb05885.x |
|---|
| Katalog-ID: |
NLEJ23945510X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLEJ23945510X | ||
| 003 | DE-627 | ||
| 005 | 20210707085343.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 120426s1991 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1111/j.1365-4362.1991.tb05885.x |2 doi | |
| 035 | |a (DE-627)NLEJ23945510X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 100 | 1 | |a Okano, Masaki |c M.D. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a 1α,25-(OH)2D3 Use on Psoriasis and Ichthyosis |
| 264 | 1 | |a Oxford, UK |b Blackwell Publishing Ltd |c 1991 | |
| 300 | |a Online-Ressource | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a : The present work compared the clinical efficacy of topically applied 1α,25-dihydroxyvitamin D3 (1α,25-(OH)2D3) in 16 cases with psoriasis vulgaris, 5 with ichthyosis vulgaris and 8 with X-linked ichthyosis. Sixty-nine percent of the psoriatic cases responded to 1α,25-(OH)2D3 therapy, whereas no ichthyotic patients responded. The present study confirms the previously suggested effectiveness of the active form of vitamin D3 for psoriasis and denies its possible efficiency against the ichthyoses. Direct suppression of hyperproliferative activity of the psoriatic epidermis is considered one of the most plausible mechanisms of 1α,25-(OH)2D3 efficacy, through examination of the aforementioned evidence. | ||
| 533 | |d 2007 |f Blackwell Publishing Journal Backfiles 1879-2005 |7 |2007|||||||||| | ||
| 773 | 0 | 8 | |i In |t International journal of dermatology |d Oxford [u.a.] : Wiley-Blackwell, 1970 |g 30(1991), 1, Seite 0 |h Online-Ressource |w (DE-627)NLEJ243927347 |w (DE-600)2020365-2 |x 1365-4632 |7 nnns |
| 773 | 1 | 8 | |g volume:30 |g year:1991 |g number:1 |g pages:0 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/j.1365-4362.1991.tb05885.x |q text/html |x Verlag |z Deutschlandweit zugänglich |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a ZDB-1-DJB | ||
| 912 | |a GBV_NL_ARTICLE | ||
| 951 | |a AR | ||
| 952 | |d 30 |j 1991 |e 1 |h 0 | ||
| author_variant |
m o mo |
|---|---|
| matchkey_str |
article:13654632:1991----::2o23sopoissn |
| hierarchy_sort_str |
1991 |
| publishDate |
1991 |
| allfields |
10.1111/j.1365-4362.1991.tb05885.x doi (DE-627)NLEJ23945510X DE-627 ger DE-627 rakwb Okano, Masaki M.D. verfasserin aut 1α,25-(OH)2D3 Use on Psoriasis and Ichthyosis Oxford, UK Blackwell Publishing Ltd 1991 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier : The present work compared the clinical efficacy of topically applied 1α,25-dihydroxyvitamin D3 (1α,25-(OH)2D3) in 16 cases with psoriasis vulgaris, 5 with ichthyosis vulgaris and 8 with X-linked ichthyosis. Sixty-nine percent of the psoriatic cases responded to 1α,25-(OH)2D3 therapy, whereas no ichthyotic patients responded. The present study confirms the previously suggested effectiveness of the active form of vitamin D3 for psoriasis and denies its possible efficiency against the ichthyoses. Direct suppression of hyperproliferative activity of the psoriatic epidermis is considered one of the most plausible mechanisms of 1α,25-(OH)2D3 efficacy, through examination of the aforementioned evidence. 2007 Blackwell Publishing Journal Backfiles 1879-2005 |2007|||||||||| In International journal of dermatology Oxford [u.a.] : Wiley-Blackwell, 1970 30(1991), 1, Seite 0 Online-Ressource (DE-627)NLEJ243927347 (DE-600)2020365-2 1365-4632 nnns volume:30 year:1991 number:1 pages:0 http://dx.doi.org/10.1111/j.1365-4362.1991.tb05885.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 30 1991 1 0 |
| spelling |
10.1111/j.1365-4362.1991.tb05885.x doi (DE-627)NLEJ23945510X DE-627 ger DE-627 rakwb Okano, Masaki M.D. verfasserin aut 1α,25-(OH)2D3 Use on Psoriasis and Ichthyosis Oxford, UK Blackwell Publishing Ltd 1991 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier : The present work compared the clinical efficacy of topically applied 1α,25-dihydroxyvitamin D3 (1α,25-(OH)2D3) in 16 cases with psoriasis vulgaris, 5 with ichthyosis vulgaris and 8 with X-linked ichthyosis. Sixty-nine percent of the psoriatic cases responded to 1α,25-(OH)2D3 therapy, whereas no ichthyotic patients responded. The present study confirms the previously suggested effectiveness of the active form of vitamin D3 for psoriasis and denies its possible efficiency against the ichthyoses. Direct suppression of hyperproliferative activity of the psoriatic epidermis is considered one of the most plausible mechanisms of 1α,25-(OH)2D3 efficacy, through examination of the aforementioned evidence. 2007 Blackwell Publishing Journal Backfiles 1879-2005 |2007|||||||||| In International journal of dermatology Oxford [u.a.] : Wiley-Blackwell, 1970 30(1991), 1, Seite 0 Online-Ressource (DE-627)NLEJ243927347 (DE-600)2020365-2 1365-4632 nnns volume:30 year:1991 number:1 pages:0 http://dx.doi.org/10.1111/j.1365-4362.1991.tb05885.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 30 1991 1 0 |
| allfields_unstemmed |
10.1111/j.1365-4362.1991.tb05885.x doi (DE-627)NLEJ23945510X DE-627 ger DE-627 rakwb Okano, Masaki M.D. verfasserin aut 1α,25-(OH)2D3 Use on Psoriasis and Ichthyosis Oxford, UK Blackwell Publishing Ltd 1991 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier : The present work compared the clinical efficacy of topically applied 1α,25-dihydroxyvitamin D3 (1α,25-(OH)2D3) in 16 cases with psoriasis vulgaris, 5 with ichthyosis vulgaris and 8 with X-linked ichthyosis. Sixty-nine percent of the psoriatic cases responded to 1α,25-(OH)2D3 therapy, whereas no ichthyotic patients responded. The present study confirms the previously suggested effectiveness of the active form of vitamin D3 for psoriasis and denies its possible efficiency against the ichthyoses. Direct suppression of hyperproliferative activity of the psoriatic epidermis is considered one of the most plausible mechanisms of 1α,25-(OH)2D3 efficacy, through examination of the aforementioned evidence. 2007 Blackwell Publishing Journal Backfiles 1879-2005 |2007|||||||||| In International journal of dermatology Oxford [u.a.] : Wiley-Blackwell, 1970 30(1991), 1, Seite 0 Online-Ressource (DE-627)NLEJ243927347 (DE-600)2020365-2 1365-4632 nnns volume:30 year:1991 number:1 pages:0 http://dx.doi.org/10.1111/j.1365-4362.1991.tb05885.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 30 1991 1 0 |
| allfieldsGer |
10.1111/j.1365-4362.1991.tb05885.x doi (DE-627)NLEJ23945510X DE-627 ger DE-627 rakwb Okano, Masaki M.D. verfasserin aut 1α,25-(OH)2D3 Use on Psoriasis and Ichthyosis Oxford, UK Blackwell Publishing Ltd 1991 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier : The present work compared the clinical efficacy of topically applied 1α,25-dihydroxyvitamin D3 (1α,25-(OH)2D3) in 16 cases with psoriasis vulgaris, 5 with ichthyosis vulgaris and 8 with X-linked ichthyosis. Sixty-nine percent of the psoriatic cases responded to 1α,25-(OH)2D3 therapy, whereas no ichthyotic patients responded. The present study confirms the previously suggested effectiveness of the active form of vitamin D3 for psoriasis and denies its possible efficiency against the ichthyoses. Direct suppression of hyperproliferative activity of the psoriatic epidermis is considered one of the most plausible mechanisms of 1α,25-(OH)2D3 efficacy, through examination of the aforementioned evidence. 2007 Blackwell Publishing Journal Backfiles 1879-2005 |2007|||||||||| In International journal of dermatology Oxford [u.a.] : Wiley-Blackwell, 1970 30(1991), 1, Seite 0 Online-Ressource (DE-627)NLEJ243927347 (DE-600)2020365-2 1365-4632 nnns volume:30 year:1991 number:1 pages:0 http://dx.doi.org/10.1111/j.1365-4362.1991.tb05885.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 30 1991 1 0 |
| allfieldsSound |
10.1111/j.1365-4362.1991.tb05885.x doi (DE-627)NLEJ23945510X DE-627 ger DE-627 rakwb Okano, Masaki M.D. verfasserin aut 1α,25-(OH)2D3 Use on Psoriasis and Ichthyosis Oxford, UK Blackwell Publishing Ltd 1991 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier : The present work compared the clinical efficacy of topically applied 1α,25-dihydroxyvitamin D3 (1α,25-(OH)2D3) in 16 cases with psoriasis vulgaris, 5 with ichthyosis vulgaris and 8 with X-linked ichthyosis. Sixty-nine percent of the psoriatic cases responded to 1α,25-(OH)2D3 therapy, whereas no ichthyotic patients responded. The present study confirms the previously suggested effectiveness of the active form of vitamin D3 for psoriasis and denies its possible efficiency against the ichthyoses. Direct suppression of hyperproliferative activity of the psoriatic epidermis is considered one of the most plausible mechanisms of 1α,25-(OH)2D3 efficacy, through examination of the aforementioned evidence. 2007 Blackwell Publishing Journal Backfiles 1879-2005 |2007|||||||||| In International journal of dermatology Oxford [u.a.] : Wiley-Blackwell, 1970 30(1991), 1, Seite 0 Online-Ressource (DE-627)NLEJ243927347 (DE-600)2020365-2 1365-4632 nnns volume:30 year:1991 number:1 pages:0 http://dx.doi.org/10.1111/j.1365-4362.1991.tb05885.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 30 1991 1 0 |
| source |
In International journal of dermatology 30(1991), 1, Seite 0 volume:30 year:1991 number:1 pages:0 |
| sourceStr |
In International journal of dermatology 30(1991), 1, Seite 0 volume:30 year:1991 number:1 pages:0 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| isfreeaccess_bool |
false |
| container_title |
International journal of dermatology |
| authorswithroles_txt_mv |
Okano, Masaki @@aut@@ |
| publishDateDaySort_date |
1991-01-01T00:00:00Z |
| hierarchy_top_id |
NLEJ243927347 |
| id |
NLEJ23945510X |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ23945510X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20210707085343.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">120426s1991 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1111/j.1365-4362.1991.tb05885.x</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ23945510X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Okano, Masaki</subfield><subfield code="c">M.D.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">1α,25-(OH)2D3 Use on Psoriasis and Ichthyosis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford, UK</subfield><subfield code="b">Blackwell Publishing Ltd</subfield><subfield code="c">1991</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">: The present work compared the clinical efficacy of topically applied 1α,25-dihydroxyvitamin D3 (1α,25-(OH)2D3) in 16 cases with psoriasis vulgaris, 5 with ichthyosis vulgaris and 8 with X-linked ichthyosis. Sixty-nine percent of the psoriatic cases responded to 1α,25-(OH)2D3 therapy, whereas no ichthyotic patients responded. The present study confirms the previously suggested effectiveness of the active form of vitamin D3 for psoriasis and denies its possible efficiency against the ichthyoses. Direct suppression of hyperproliferative activity of the psoriatic epidermis is considered one of the most plausible mechanisms of 1α,25-(OH)2D3 efficacy, through examination of the aforementioned evidence.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="d">2007</subfield><subfield code="f">Blackwell Publishing Journal Backfiles 1879-2005</subfield><subfield code="7">|2007||||||||||</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">International journal of dermatology</subfield><subfield code="d">Oxford [u.a.] : Wiley-Blackwell, 1970</subfield><subfield code="g">30(1991), 1, Seite 0</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)NLEJ243927347</subfield><subfield code="w">(DE-600)2020365-2</subfield><subfield code="x">1365-4632</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:30</subfield><subfield code="g">year:1991</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1111/j.1365-4362.1991.tb05885.x</subfield><subfield code="q">text/html</subfield><subfield code="x">Verlag</subfield><subfield code="z">Deutschlandweit zugänglich</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DJB</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">30</subfield><subfield code="j">1991</subfield><subfield code="e">1</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| series2 |
Blackwell Publishing Journal Backfiles 1879-2005 |
| author |
Okano, Masaki M.D. |
| spellingShingle |
Okano, Masaki M.D. 1α,25-(OH)2D3 Use on Psoriasis and Ichthyosis |
| authorStr |
Okano, Masaki M.D. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)NLEJ243927347 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
NL |
| publishPlace |
Oxford, UK |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
1365-4632 |
| topic_title |
1α,25-(OH)2D3 Use on Psoriasis and Ichthyosis |
| publisher |
Blackwell Publishing Ltd |
| publisherStr |
Blackwell Publishing Ltd |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| hierarchy_parent_title |
International journal of dermatology |
| hierarchy_parent_id |
NLEJ243927347 |
| hierarchy_top_title |
International journal of dermatology |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)NLEJ243927347 (DE-600)2020365-2 |
| title |
1α,25-(OH)2D3 Use on Psoriasis and Ichthyosis |
| ctrlnum |
(DE-627)NLEJ23945510X |
| title_full |
1α,25-(OH)2D3 Use on Psoriasis and Ichthyosis |
| author_sort |
Okano, Masaki M.D. |
| journal |
International journal of dermatology |
| journalStr |
International journal of dermatology |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
1991 |
| contenttype_str_mv |
zzz |
| container_start_page |
0 |
| author_browse |
Okano, Masaki |
| container_volume |
30 |
| physical |
Online-Ressource |
| format_se |
Elektronische Aufsätze |
| author-letter |
Okano, Masaki |
| doi_str_mv |
10.1111/j.1365-4362.1991.tb05885.x |
| title_sort |
1α,25-(oh)2d3 use on psoriasis and ichthyosis |
| title_auth |
1α,25-(OH)2D3 Use on Psoriasis and Ichthyosis |
| abstract |
: The present work compared the clinical efficacy of topically applied 1α,25-dihydroxyvitamin D3 (1α,25-(OH)2D3) in 16 cases with psoriasis vulgaris, 5 with ichthyosis vulgaris and 8 with X-linked ichthyosis. Sixty-nine percent of the psoriatic cases responded to 1α,25-(OH)2D3 therapy, whereas no ichthyotic patients responded. The present study confirms the previously suggested effectiveness of the active form of vitamin D3 for psoriasis and denies its possible efficiency against the ichthyoses. Direct suppression of hyperproliferative activity of the psoriatic epidermis is considered one of the most plausible mechanisms of 1α,25-(OH)2D3 efficacy, through examination of the aforementioned evidence. |
| abstractGer |
: The present work compared the clinical efficacy of topically applied 1α,25-dihydroxyvitamin D3 (1α,25-(OH)2D3) in 16 cases with psoriasis vulgaris, 5 with ichthyosis vulgaris and 8 with X-linked ichthyosis. Sixty-nine percent of the psoriatic cases responded to 1α,25-(OH)2D3 therapy, whereas no ichthyotic patients responded. The present study confirms the previously suggested effectiveness of the active form of vitamin D3 for psoriasis and denies its possible efficiency against the ichthyoses. Direct suppression of hyperproliferative activity of the psoriatic epidermis is considered one of the most plausible mechanisms of 1α,25-(OH)2D3 efficacy, through examination of the aforementioned evidence. |
| abstract_unstemmed |
: The present work compared the clinical efficacy of topically applied 1α,25-dihydroxyvitamin D3 (1α,25-(OH)2D3) in 16 cases with psoriasis vulgaris, 5 with ichthyosis vulgaris and 8 with X-linked ichthyosis. Sixty-nine percent of the psoriatic cases responded to 1α,25-(OH)2D3 therapy, whereas no ichthyotic patients responded. The present study confirms the previously suggested effectiveness of the active form of vitamin D3 for psoriasis and denies its possible efficiency against the ichthyoses. Direct suppression of hyperproliferative activity of the psoriatic epidermis is considered one of the most plausible mechanisms of 1α,25-(OH)2D3 efficacy, through examination of the aforementioned evidence. |
| collection_details |
GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE |
| container_issue |
1 |
| title_short |
1α,25-(OH)2D3 Use on Psoriasis and Ichthyosis |
| url |
http://dx.doi.org/10.1111/j.1365-4362.1991.tb05885.x |
| remote_bool |
true |
| ppnlink |
NLEJ243927347 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.1111/j.1365-4362.1991.tb05885.x |
| up_date |
2024-07-06T07:31:45.310Z |
| _version_ |
1803814023001538560 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ23945510X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20210707085343.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">120426s1991 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1111/j.1365-4362.1991.tb05885.x</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ23945510X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Okano, Masaki</subfield><subfield code="c">M.D.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">1α,25-(OH)2D3 Use on Psoriasis and Ichthyosis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford, UK</subfield><subfield code="b">Blackwell Publishing Ltd</subfield><subfield code="c">1991</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">: The present work compared the clinical efficacy of topically applied 1α,25-dihydroxyvitamin D3 (1α,25-(OH)2D3) in 16 cases with psoriasis vulgaris, 5 with ichthyosis vulgaris and 8 with X-linked ichthyosis. Sixty-nine percent of the psoriatic cases responded to 1α,25-(OH)2D3 therapy, whereas no ichthyotic patients responded. The present study confirms the previously suggested effectiveness of the active form of vitamin D3 for psoriasis and denies its possible efficiency against the ichthyoses. Direct suppression of hyperproliferative activity of the psoriatic epidermis is considered one of the most plausible mechanisms of 1α,25-(OH)2D3 efficacy, through examination of the aforementioned evidence.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="d">2007</subfield><subfield code="f">Blackwell Publishing Journal Backfiles 1879-2005</subfield><subfield code="7">|2007||||||||||</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">International journal of dermatology</subfield><subfield code="d">Oxford [u.a.] : Wiley-Blackwell, 1970</subfield><subfield code="g">30(1991), 1, Seite 0</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)NLEJ243927347</subfield><subfield code="w">(DE-600)2020365-2</subfield><subfield code="x">1365-4632</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:30</subfield><subfield code="g">year:1991</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1111/j.1365-4362.1991.tb05885.x</subfield><subfield code="q">text/html</subfield><subfield code="x">Verlag</subfield><subfield code="z">Deutschlandweit zugänglich</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DJB</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">30</subfield><subfield code="j">1991</subfield><subfield code="e">1</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| score |
7.4010983 |